Skip to main content
SpringerLink
Log in

Eugenol-loaded mesoporous silica nanoparticles enhance the sensitivity of cisplatin against AGS human gastric adenocarcinoma cell line

  • Research paper
  • Published:
Journal of Nanoparticle Research Aims and scope Submit manuscript

Abstract

Gastric cancer is one of the most common cancers with a high mortality rate worldwide. Eugenol possesses antioxidant, anti-inflammatory, antimicrobial, and anticancer properties. Mesoporous silica nanoparticles (MSN) have been promising carriers for drug delivery. This study aimed to investigate the synergism effect of free eugenol/eugenol-MSN and cisplatin on the AGS human gastric adenocarcinoma cell line. In this study, MSN was synthesized and loaded with eugenol. Cultured AGS cells were treated with different concentrations of free eugenol/eugenol-MSN individually and in combination with cisplatin. MTT assay, scratch assay, and flow cytometry were employed to assess cell viability, migration, and apoptosis. The antioxidant properties of free eugenol/eugenol-MSN and their effect on superoxide dismutase (SOD) activity were evaluated. Real-time PCR was used to study the effect of free eugenol/eugenol-MSN on the expression of metastatic pathway genes such as MMP2, MMP9, and KRAS, and some genes involved in apoptosis including caspase 3, caspase 8, and caspase 9. A synergism effect of free eugenol/eugenol-MSN and cisplatin (CI < 1) was observed. Combination therapies were significantly more effective in cell growth reduction, migration inhibition, and apoptosis induction than single treatments. Free eugenol has more potential in DPPH radical scavenging, and eugenol-MSN has more potential in increasing SOD activity. The relative expression of caspase 3, caspase 8, and caspase 9 genes in the treated cells increased compared to the control group, and the expression of MMP2, MMP9, and KRAS oncogenes decreased significantly. Eugenol loading in MSN leads to increasing the sensitivity of cisplatin against gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data Availability

The data that support the findings of this study are available from the authors upon reasonable request.

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

    Article  Google Scholar 

  2. Joshi SS, Badgwell BD (2021) Current treatment and recent progress in gastric cancer. CA Cancer J Clin 71:264–279

    Article  Google Scholar 

  3. Martinho N, Santos TC, Florindo HF, Silva LC (2019) Cisplatin-membrane interactions and their influence on platinum complexes activity and toxicity. Front Physiol 9:1898

    Article  Google Scholar 

  4. Hannon MJ (2007) Metal-based anticancer drugs: from a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology. Pure Appl Chem 79:2243–2261

    Article  CAS  Google Scholar 

  5. Stewart DJ (2007) Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol 63:12–31

    Article  Google Scholar 

  6. Khalil AA, ur Rahman U, Khan MR, Sahar A, Mehmood T, Khan M (2017) Essential oil eugenol: sources, extraction techniques and nutraceutical perspectives. RSC Adv 7:32669-32681

  7. Mak K-K, Kamal M, Ayuba S, Sakirolla R, Kang Y-B, Mohandas K et al (2019) A comprehensive review on eugenol’s antimicrobial properties and industry applications: a transformation from ethnomedicine to industry. Pharmacogn Rev 13:1–9

    Article  CAS  Google Scholar 

  8. Marchese A, Barbieri R, Coppo E, Orhan IE, Daglia M, Nabavi SF et al (2017) Antimicrobial activity of eugenol and essential oils containing eugenol: a mechanistic viewpoint. Crit Rev Microbiol 43:668–689

    Article  CAS  Google Scholar 

  9. Barboza JN, da Silva Maia BFC, Silva RO, Medeiros JVR, de Sousa DP (2018) An overview on the anti-inflammatory potential and antioxidant profile of eugenol. Oxid Med Cell Longev 2018:1–9

  10. Nisar MF, Khadim M, Rafiq M, Chen J, Yang Y, Wan CC (2021) Pharmacological properties and health benefits of eugenol: a comprehensive review. Oxid Med Cell Longev 2021:1–14

  11. Abdullah ML, Hafez MM, Al-Hoshani A, Al-Shabanah O (2018) Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells. BMC Complement Altern Med 18:1–11

    Article  Google Scholar 

  12. Pisano M, Pagnan G, Loi M, Mura ME, Tilocca MG, Palmieri G et al (2007) Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. Mol Cancer 6:1–12

    Article  Google Scholar 

  13. Hussain A, Brahmbhatt K, Priyani A, Ahmed M, Rizvi TA, Sharma C (2011) Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. Cancer Biother Radiopharm 26:519–527

    CAS  Google Scholar 

  14. Islam SS, Al-Sharif I, Sultan A, Al-Mazrou A, Remmal A, Aboussekhra A (2018) Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway. Mol Carcinog 57:333–346

    Article  CAS  Google Scholar 

  15. Yi J-L, Shi S, Shen Y-L, Wang L, Chen H-Y, Zhu J et al (2015) Myricetin and methyl eugenol combination enhances the anticancer activity, cell cycle arrest and apoptosis induction of cis-platin against HeLa cervical cancer cell lines. Int J Clin Exp Pathol 8:1116

    Google Scholar 

  16. Fangjun L, Zhijia Y (2018) Tumor suppressive roles of eugenol in human lung cancer cells. Thorac Cancer 9:25–29

    Article  Google Scholar 

  17. Carrasco AH, Espinoza CL, Cardile V, Gallardo C, Cardona W, Lombardo L et al (2008) Eugenol and its synthetic analogues inhibit cell growth of human cancer cells (Part I). J Braz Chem Soc 19:543–548

    Article  Google Scholar 

  18. de Sa Junior PL, Câmara DAD, Costa AS, Ruiz JLM, Levy D, Azevedo RA et al (2016) Apoptotic effect of eugenol envolves G2/M phase abrogation accompanied by mitochondrial damage and clastogenic effect on cancer cell in vitro. Phytomedicine 23:725–735

    Article  Google Scholar 

  19. Yoo C-B, Han K-T, Cho K-S, Ha J, Park H-J, Nam J-H et al (2005) Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Lett 225:41–52

    Article  CAS  Google Scholar 

  20. Jaganathan SK, Mazumdar A, Mondhe D, Mandal M (2011) Apoptotic effect of eugenol in human colon cancer cell lines. Cell Biol Int 35:607–615

    Article  CAS  Google Scholar 

  21. Tran S, DeGiovanni P-J, Piel B, Rai P (2017) Cancer nanomedicine: a review of recent success in drug delivery. Clin Transl Med 6:1–21

    Article  Google Scholar 

  22. Haider M, Abdin SM, Kamal L, Orive G (2020) Nanostructured lipid carriers for delivery of chemotherapeutics: A review. Pharmaceutics 12:288

    Article  CAS  Google Scholar 

  23. Sarkar A, Ghosh S, Chowdhury S, Pandey B, Sil PC (2016) Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells. BiochimBiophys Acta (BBA) Gen Subj 1860:2065–2075

  24. Argyo C, Weiss V, Bräuchle C, Bein T (2014) Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem Mater 26:435–451

    Article  CAS  Google Scholar 

  25. Mai WX, Meng H (2013) Mesoporous silica nanoparticles: a multifunctional nano therapeutic system. Integr Biol 5:19–28

    Article  CAS  Google Scholar 

  26. Ma’Mani L, Nikzad S, Kheiri-Manjili H, Al-Musawi S, Saeedi M, Askarlou S et al (2014) Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy. Eur J Med Chem 83:646–654

    Article  CAS  Google Scholar 

  27. Alyassin Y, Sayed EG, Mehta P, Ruparelia K, Arshad MS, Rasekh M et al (2020) Application of mesoporous silica nanoparticles as drug delivery carriers for chemotherapeutic agents. Drug Discov Today 25:1513–1520

    Article  CAS  Google Scholar 

  28. Fan J, Fang G, Wang X, Zeng F, Xiang Y, Wu S (2011) Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology 22:455102

    Article  Google Scholar 

  29. Brunauer S, Emmett PH, Teller E (1938) Adsorption of gases in multimolecular layers. J Am Chem Soc 60:309–319

    Article  CAS  Google Scholar 

  30. Chou T-C, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27–55

    Article  CAS  Google Scholar 

  31. Fu J, Zhang N, Chou JH, Dong H-J, Lin S-F, Ulrich-Merzenich GS et al (2016) Drug combination in vivo using combination index method: Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice. Synergy 3:15–30

    Article  Google Scholar 

  32. Seux M, Peuget S, Montero M, Siret C, Rigot V, Clerc P et al (2011) TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression. Oncogene 30:3049–3061

    Article  CAS  Google Scholar 

  33. Kedare SB, Singh R (2011) Genesis and development of DPPH method of antioxidant assay. J Food Sci Technol 48:412–422

    Article  CAS  Google Scholar 

  34. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 25:402–408

    Article  CAS  Google Scholar 

  35. Zagidullin B, Aldahdooh J, Zheng S, Wang W, Wang Y, Saad J et al (2019) DrugComb: an integrative cancer drug combination data portal. Nucleic Acids Res 47:W43–W51

    Article  CAS  Google Scholar 

  36. Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H (2012) Nanoparticles as drug delivery systems. Pharmacol Rep 64:1020–1037

    Article  CAS  Google Scholar 

  37. Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56:1649–1659

    Article  CAS  Google Scholar 

  38. Gurunathan S, Kang M-H, Qasim M, Kim J-H (2018) Nanoparticle-mediated combination therapy: Two-in-one approach for cancer. Int J Mol Sci 19:3264

    Article  Google Scholar 

  39. Jeong J-M, Choi C-H, Kang S-K, Lee I-H, Lee J-Y, Jung H (2007) Antioxidant and chemosensitizing effects of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship. J Pharm Pharm Sci 10:537–546

    Article  CAS  Google Scholar 

  40. Attia MF, Anton N, Wallyn J, Omran Z, Vandamme TF (2019) An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites. J Pharm Pharmacol 71:1185–1198

    Article  CAS  Google Scholar 

  41. Golombek SK, May J-N, Theek B, Appold L, Drude N, Kiessling F et al (2018) Tumor targeting via EPR: Strategies to enhance patient responses. Adv Drug Deliv Rev 130:17–38

    Article  CAS  Google Scholar 

  42. Watermann A, Brieger J (2017) Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials 7:189

    Article  Google Scholar 

  43. Lungare S, Hallam K, Badhan RK (2016) Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery. Int J Pharm 513:280–293

    Article  CAS  Google Scholar 

  44. Nasr SS, Nasra M, Hazzah HA, Abdallah OY (2019) Mesoporous silica nanoparticles, a safe option for silymarin delivery: preparation, characterization, and in vivo evaluation. Drug Deliv Transl Res 9:968–979

    Article  CAS  Google Scholar 

  45. Freidus LG, Kumar P, Marimuthu T, Pradeep P, Choonara YE (2021) Theranostic Mesoporous Silica Nanoparticles Loaded With a Curcumin-Naphthoquinone Conjugate for Potential Cancer Intervention. Front Mol Biosci 8:670792

    Article  CAS  Google Scholar 

  46. Manikandan P, Vinothini G, VidyaPriyadarsini R, Prathiba D, Nagini S (2011) Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG. Investig New Drugs 29:110–117

    Article  CAS  Google Scholar 

  47. Manikandan P, Murugan RS, Priyadarsini RV, Vinothini G, Nagini S (2010) Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. Life Sci 86:936–941

    Article  CAS  Google Scholar 

  48. Sarkar A, Bhattacharjee S, Mandal DP (2015) Induction of apoptosis by eugenol and capsaicin in human gastric cancer AGS cells-elucidating the role of p53. Asian Pac J Cancer Prev 16:6753–6759

    Article  Google Scholar 

  49. Vidhya N, Devaraj SN (2011) Induction of apoptosis by eugenol in human breast cancer cells. Indian J Exp Biol 49(11):871–8

  50. Abdullah ML, Al-Shabanah O, Hassan ZK, Hafez MM (2021) Eugenol-induced autophagy and apoptosis in breast cancer cells via PI3K/AKT/FOXO3a pathway inhibition. Int J Mol Sci 22:9243

    Article  CAS  Google Scholar 

  51. Permatasari HK, Effendi AB, Qhabibi FR, Fawwaz F, Dominique A (2021) Eugenol isolated from Syzygium aromaticum inhibits HeLa cancer cell migration by altering epithelial-mesenchymal transition protein regulators. J Appl Pharm Sci 11:049-053

  52. Das A, Harshadha K, SK DK, Jayaprakash B (2018) Evaluation of therapeutic potential of eugenol-a natural derivative of Syzygiumaromaticum on cervical cancer. Asian Pac J Cancer Prev: APJCP 19:1977

  53. Cui Z, Liu Z, Zeng J, Chen L, Wu Q, Mo J et al (2019) Eugenol inhibits non-small cell lung cancer by repressing expression of NF-κB-regulated TRIM59. Phytother Res 33:1562–1569

    Article  CAS  Google Scholar 

  54. Kim G-C, Choi D-S, Lim J-S, Jeong H-C, Kim I-R, Lee M-H et al (2006) Caspases-dependent apoptosis in human melanoma cell by eugenol. Korean J Anat 39:245–253

  55. Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP (2005) Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem 280:5812–5819

    Article  CAS  Google Scholar 

  56. Majeed H, Antoniou J, Fang Z (2014) Apoptotic effects of eugenol-loaded nanoemulsions in human colon and liver cancer cell lines. Asian Pac J Cancer Prev 15:9159–9164

    Article  Google Scholar 

  57. Fathy M, Fawzy MA, Hintzsche H, Nikaido T, Dandekar T, Othman EM (2019) Eugenol exerts apoptotic effect and modulates the sensitivity of HeLa cells to cisplatin and radiation. Molecules 24:3979

    Article  CAS  Google Scholar 

  58. Islam SS, Aboussekhra A (2019) Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway. J Exp Clin Cancer Res 38:1–14

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was financially supported by Shahrekord University (grant no.0GRD34M32855). We thank all cooperating with us in conduction of this project, particularly the respectful populates and officials of Shahrekord University.

Author information

Authors and Affiliations

  1. Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran

    Shahrzad Shahbazi & Somayeh Reiisi

  2. Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical Sciences, Shahrekord, Iran

    Razieh Heidari

  3. Department of Physics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran

    Morteza Raeisi

Authors
  1. Shahrzad Shahbazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Somayeh Reiisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Razieh Heidari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Morteza Raeisi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Sh. Shahbazi performed most of the experiments as part of his master’s degree in biotechnology. R. Heidari and M. Raeisi were thesis advisors and participated in intellectual discussions of the data. S. Reiisi coordinated the study, designed the experiments, and revised the manuscript.

Corresponding author

Correspondence to Somayeh Reiisi.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shahbazi, S., Reiisi, S., Heidari, R. et al. Eugenol-loaded mesoporous silica nanoparticles enhance the sensitivity of cisplatin against AGS human gastric adenocarcinoma cell line. J Nanopart Res 25, 57 (2023). https://doi.org/10.1007/s11051-023-05712-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11051-023-05712-7

Keywords

Search

Navigation